Drug-induced myopathies. An overview of the possible mechanisms.

Journal Title: Pharmacological Reports - Year 2005, Vol 57, Issue 1

Abstract

Myopathy is usually a non-fatal muscle disease involving skeletal muscle weakness, tenderness and pain with the possibility of the plasma creatinine kinase elevation. There are many different types of myopathies, some of which are genetic, inflammatory, or related to endocrine dysfunction. Also, numerous drugs have been reported to possess myotoxic effect. Myopathy is included among the potential side-effects and toxicities associated with the lipid lowering agents, particularly 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. However, the precise mechanism of statin-induced muscle toxicity remains unclear. The muscle-related side-effects reported with lipid-lowering drugs are significant but quite rare (0.1%), when used in monotherapy; while the incidence of steroid-induced myopathy has varied from 7 to 60%% and chronic alcoholic myopathy seems to be common complication of alcoholism affecting approximately 50% of patients, respectively. This review focuses on the differential pathophysiological grounds of these muscular injuries induced by statins, fibrates, as well as some other agents: corticosteroids or alcohol. A wide spectrum of possible mechanisms and hypotheses including muscle enzyme defects, changes in mitochondrial function and intracellular metabolism, the influence on the cell membrane stability and drug interactions involving P-glycoprotein or cytochrome P 450 system have been presented.

Authors and Affiliations

Jacek Owczarek, Magdalena Jasińska, Daria Orszulak-Michalak

Keywords

Related Articles

Involvement of spinal PKA/CREB signaling pathway in the development of bone cancer pain.

Background: It has been shown that spinal PKA/CREB signaling pathway is involved in neuropathic and inflammatory pain, but its effects on bone cancer pain have not previously been investigated. The aim of this study was...

Neuroprotective potential of mGluR5 antagonist MTEP: effects on kainate-induced excitotoxicity in the rat hippocampus.

Extensive research into glutamate receptors in the central nervous system has shown important role of metabotropic glutamate receptors (mGluR) as potential targets for neuroprotective drugs. The aim of the present study...

Pharmacological activity of calcimimetic NPS R-568 administered intravenously in rats: dose dependency.

Calcimimetics administered orally cause "pharmacological parathyroidectomy" confirmed by a decrease in parathyroid hormone secretion (PTH) and in plasma Ca(2+) concentration. Parathyroidsare also the source of parathyroi...

CYP2D6 phenotyping with dextromethorphan.

Genetically determined individual differences in the ability to oxidize certain drugs have raised recently a considerable interest because of clinical importance of this problem. Determination of CYP2D6 oxidation phenoty...

Eplerenone promotes alternative activation in human monocyte-derived macrophages.

Background: In this study, we have analyzed the response of human monocyte-derived macrophages to mineralocorticoid axis modulators. Methods: Human monocyte-derived macrophages were incubated with aldosterone alone, eple...

Download PDF file
  • EP ID EP82259
  • DOI -
  • Views 181
  • Downloads 0

How To Cite

Jacek Owczarek, Magdalena Jasińska, Daria Orszulak-Michalak (2005). Drug-induced myopathies. An overview of the possible mechanisms.. Pharmacological Reports, 57(1), 23-34. https://europub.co.uk/articles/-A-82259